SMS Pharmaceuticals Limited — Others, 02-06-2025: Copy of Newspaper Publication

SMS Pharmaceuticals has announced a board meeting to consider the financial results for the quarter and half-year. The company is progressing well operationally, with manufacturing and quality processes aligned with regulatory standards. It remains compliant with corporate governance requirements and reported no material changes affecting business continuity. The update includes the latest shareholding pattern and underscores the company’s commitment to transparency, reinforcing investor confidence in its steady management and disclosure practices.